搜索
Milestone Pharmaceuticals Inc
MIST添加自选
0.801USD
-0.061-7.08%
交易中 09/24, 13:36（美东）
99.72M总市值
亏损市盈率 TTM
关于 Milestone Pharmaceuticals Inc 公司
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Milestone Pharmaceuticals Inc 简介
公司代码MIST
公司名称Milestone Pharmaceuticals Inc
上市日期May 09, 2019
CEOOliveto (Joseph)
员工数量33
证券类型Ordinary Share
年结日May 09
公司地址420-1111 boul. Dr.-Frederik-Philips
城市MONTREAL
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编H4M 2X6
电话15143360444
网址https://www.milestonepharma.com
公司代码MIST
上市日期May 09, 2019
CEOOliveto (Joseph)
Milestone Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
Mr. Joseph C. Papa
Mr. Joseph C. Papa
Independent Director
Independent Director
100.00K
--
常见问题
Milestone Pharmaceuticals Inc的前五大股东是谁？
Milestone Pharmaceuticals Inc 的前五大股东如下：Dr. David Bharucha
有多少机构持有Milestone Pharmaceuticals Inc(MIST)的股份？
截至2026Q1，共有133家机构持有Milestone Pharmaceuticals Inc的股份，合计持有的股份价值约为30.89M，占公司总股份的25.86%。与2025Q4相比，机构持股有所增加，增幅为-18702702.00。